Universe Pharma: August Luck discloses 9.29% stake
The Schedule 13G filing shows August Luck Global Limited and Xuefeng Li hold 465,258 Class A shares, or 9.29%, with shared voting and dispositive power.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Universe Pharmaceuticals INC (UPC) received a Schedule 13G reporting that August Luck Global Limited and Xuefeng Li together beneficially own 465,258 Class A ordinary shares. This represents 9.29% of the Class A ordinary shares, based on 5,008,313 shares outstanding as of July 27, 2026.
The 465,258 shares are held by August Luck Global Limited, a British Virgin Islands company that is wholly owned and controlled by Xuefeng Li of the People’s Republic of China. Both reporting persons disclose shared voting and dispositive power over these shares, with no sole voting or dispositive power.
Key Figures
Key Terms
beneficially owned financial
Schedule 13G regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Universe Pharmaceuticals INC (UPC) does August Luck Global Limited beneficially own?
What is the relationship between August Luck Global Limited and Xuefeng Li in the UPC Schedule 13G?
AI-generated analysis. How Rhea-AI works. Not financial advice.